Autoimmune Haemolytic Anaemia
Immunology·MeSH: Anemia, Hemolytic, Autoimmune
Prevalence
5.0 / 100K
2 drugs in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| sar445088 | Sanofi (SNY) |
Phase 1(1)
| Drug | Company |
|---|---|
| bivv020 | Sanofi (SNY) |
Compare drugs
Frequently asked questions
How many drugs are in development for Autoimmune Haemolytic Anaemia?
BioSniper tracks 2 drugs in development for Autoimmune Haemolytic Anaemia across 1 company.
How many clinical trials target Autoimmune Haemolytic Anaemia?
There are 3 clinical trials targeting Autoimmune Haemolytic Anaemia tracked by BioSniper.
What is the prevalence of Autoimmune Haemolytic Anaemia?
The estimated prevalence of Autoimmune Haemolytic Anaemia is approximately 5.0 per 100,000 population.
Deep-dive into Autoimmune Haemolytic Anaemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis